Access Total T3, Access Thyroglobulin, Access Free T4, Access GI Monitor 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Beckman Coulter 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2017-05-15
  • 사례 출판 날짜
    2017-05-15
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: beckman coulter access total t3, access thyroglobulin, access free t4, access gi monitor medical device manufacturer, beckman coulter, has issued a medical device safety alert concerning its access total t3, access thyroglobulin, access free t4, access gi monitor [reference numbers: 3380 (total t3), 33860 (thyroglobulin), 33880 (free t4), 387687 (gi monitor); lot numbers: all] for use with the access family of immunoassay systems. the manufacturer has determined through customer feedback and internal investigation that the four access immunoassays listed above are susceptible to biotin interference. during interference testing the interference occurred with samples that contained 100 ng/ml of biotin. this level of biotin is greater than the maximum biotin concentration observed in the normal healthy population. according to the manufacturer, specimens from patients who are undergoing biotin therapy and/or ingesting biotin supplements may contain high levels of biotin. the higher biotin concentration in these specimens interferes with the biotin-streptavidin assay design of the four access assays listed previously. other access assays with a biotin-streptavidin assay design were also tested. these assays are not affected by higher biotin concentrations. specimens that contain high levels of biotin may cause: false low results for the access gi monitor and thyroglobulin assays. false high results for the access free t4 and total t3 assays. the customers are advised to take following actions: interpret results in light of the total clinical presentation of the patient, including: symptoms, clinical history, data from additional tests, and other appropriate information. a retrospective review of results is not recommended. the manufacturer will update the limitations section of the access total t3, thyroglobulin, free t4, and gi monitor instructions for use with this biotin interference information. according to the local supplier, the affected products are distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 15 may 2017.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Beckman Coulter Access Total T3, Access Thyroglobulin, Access Free T4, Access GI Monitor
  • Manufacturer

Manufacturer